Arcturus Therapeutics
Price & Volume
Stats
See more52W Range | $8.04-$25.88 |
Market Cap | $602M |
Shares Short | 5M |
Financials
See moreRevenue (12 Mos) | $122.1M |
Revenue Growth (YoY) | -43.2% |
Gross Profit (12 Mos) | -$70.9M |
Diluted EPS | -$2.22 |
News
See moreYahoo Finance • 2 months ago
Meta, Goldman Sachs lead Tuesday's market cap stock movers
Yahoo Finance • 2 months ago
Top movers in Tuesday's session
Yahoo Finance • 2 months ago
Wells Fargo lowers Arcturus Therapeutics stock price target to $42 on model updates
Yahoo Finance • 2 months ago
Arcturus outlines pivotal trial plans and advances CF and OTC programs with regulatory meetings expected in 2026
About
CEO | Mr. Joseph E. Payne M.Sc. |
CFO | Mr. Andrew H. Sassine MBA |
Address | 10628 Science Center Drive, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 174 |
